Opioid Addiction Victims
An OxyContin lawsuit settlement agreement is in the works that will provide relief to families and victims of opioid addiction and overdoses. Purdue Pharma, makers of OxyContin and other opioids, is being held accountable for misrepresenting the risk of long-term use of their drugs, heavily contributing to America’s opioid crisis. Details of the Purdue Pharma settlement are still being finalized, but after filing for bankruptcy, Purdue Pharma has agreed to pay billions to creditors. If you or a loved one were affected by opioid addiction or related complications, it’s important to contact our Purdue Pharma bankruptcy attorneys as soon as possible so we can determine whether you could be eligible for compensation.
Please note that as the court ordered that all claims must be filed on or before June 30, 2020, all claimants must submit a signed retainer by June 1, 2020, so that we have the time to prepare the required documents and documentation. So please don’t hesitate: Contact us now if you think you might be entitled to compensation from the proposed Purdue Pharma Bankruptcy Trust.
Who Is Eligible to Join the Lawsuit Against Purdue Pharma?
Those eligible to join the class-action lawsuit against OxyContin’s manufacturer must have taken one of Purdue Pharma’s brand-name drugs and have experienced one of four injuries related to opioid use.
Purdue Pharma produces the following brand-name drugs:
- MS Contin
- Hysingla ER
- DHC Plus
To be eligible for the settlement, the individual in question must have taken one of the drugs on this list. They also must have suffered one of the following consequences of using the drug:
- Death by overdose between 2016 and the present
- An overdose without death between 2016 and the present
- Addiction leading to a significant event such as the loss of employment, diagnosis of a substance abuse disorder, or loss of custody of a child
- The birth of a child with neonatal abstinence syndrome (NAS) or NAS-related complications, such as a learning disability, spina bifida, a developmental disability, a heart defect, or congenital defects or malformations
If you or your loved one meet the conditions described above, contact one of our lawyers right away to be eligible to collect the compensation you are owed.
Purdue Pharma’s Opioid Crisis Responsibility
Purdue Pharma’s Oxycontin Addiction
Purdue Pharma produces the drug OxyContin, and they are one of several drug companies that have been sued for grossly misrepresenting how dangerous and addictive opioid drugs can be. According to the White House Council of Economic Advisers, the opioid crisis caused by use and abuse of these prescription drugs has cost the United States more than $504 million. Prescription opioids can be highly addictive, leading to health complications and the risk of overdose. Because opioids slow breathing and interfere with oxygen intake, thousands of people have died of an opioid overdose.
It was the responsibility of Purdue Pharma and other companies to inform the public and medical professionals of the dangers of long-term use of this product. Their failure to do so means that families and individuals strongly impacted by opioid addiction are entitled to compensation. At Parker Waichman LLP, we are knowledgeable Purdue Pharma bankruptcy attorneys who can help you find out if you’re eligible to join the settlement in this case. Please contact us as soon as possible: This is a time-sensitive matter.
OxyContin: Painkiller and Addiction-Maker
OxyContin is a narcotic painkiller used to treat severe pain. It’s a time-released version of oxycodone that lasts up to 12 hours per dose. It’s also highly addictive and has caused many overdose deaths. Purdue Pharma is responsible for warning consumers of the risks of OxyContin, and their failure to do so, paired with an aggressive and misleading advertising campaign that fueled astronomical growth in prescription rates, makes the company liable for losses and damages inflicted on those affected by OxyContin overdoses and addiction. The company overstated the drug’s effectiveness and safety for long-term chronic pain, which has led to addiction for many people. If you have suffered pain and loss because of this medication, you may be eligible to join the Purdue Pharma OxyContin lawsuit settlement. Contact one of our lawyers to review your case today.
Ryzolt: Weaker But Not Safer
Ryzolt, an extended-release form of tramadol hydrochloride, is prescribed to treat chronic and acute pain from illnesses like fibromyalgia, cancer, and rheumatoid arthritis. It’s a weaker type of painkiller than OxyContin, but this can lead to patients taking larger doses of the drug, which can lead to overdoses and addiction. Thousands of people have suffered from addiction and overdoses after taking this drug. The drug should be used cautiously in elderly patients, yet Purdue Pharma used advertisements targeted at veterans and the elderly to sell its medications. If Ryzolt has negatively impacted your life, contact one of our lawyers today.
MS Contin: One of the Oldest Opioids
We’ve all heard of OxyContin, but what is MS Contin? The answer is that MS Contin is a long-acting form of morphine, which has been around since the 1800s. Its addictive effects were evident as early as the Civil War, when soldiers were given morphine for their injuries and returned home dependent on the drug. Today, MS Contin is used to treat severe, long-term, around-the-clock pain. It’s also made by Purdue Pharma, OxyContin’s manufacturer, and it has the same high potential for abuse. It can also cause respiratory depression, which has claimed lives. If you or a loved one have been negatively impacted by this drug, contact our Purdue Pharma bankruptcy lawyers today.
Dilaudid, Butrans, and Other Purdue Phrama Opioids
While OxyContin, Ryzolt, and MS Contin are some of the most frequently prescribed opioids, they’re far from the only Purdue Pharma medications that have had devastating effects on people’s lives. Other common drugs named in the Purdue Pharma lawsuit include Dilaudid and Palladone, brand names for hydromorphone; Butrans, or buprenorphine; Oxyfast and OxyIR, formulations of oxycodone; MSIR, a formulation of morphine; Hysingla ER, a brand name of hydrocodone; and DHC Plus, a combination medication that contains dihydrocodeine. If you or a loved one took any of these medications and experienced an addiction or loss as a result, you may be entitled to join the Purdue Pharma lawsuit.
Justice for Families of Deceased Opioid Overdose Victims
According to the CDC, on average, 46 people die every day from overdoses involving opioid drugs. Overdose rates increase significantly for people over 65 years old, and OxyContin is one of the most common opioid drugs involved in overdose deaths. In addition, people addicted to prescription opioids sometimes turn to heroin when they lose access to or can’t afford the prescription drug. Purdue Pharma had a duty to warn consumers about the dangers of long-term use of their products, and their failure to do so means that if you have lost a loved one to an opioid overdose, you deserve justice. We can help: Contact our lawyers about joining the Purdue Pharma lawsuit today.
Help for Victims of
The American opioid crisis is ongoing, claiming thousands and thousands of victims of opioid overdoses. Unfortunately, lawsuits alone won’t stop the crisis, but we are making significant strides toward holding pharmaceutical companies accountable for the pain they’ve caused so many. Because of the addictive nature of Purdue Pharma’s opioid drugs, far too many people have overdosed on OxyContin and similar medications. Thankfully, some of them survive the experience, but pain, complications, injuries, and medical bills are just a few struggles that those who have dealt with an opioid overdose have had to face. Contact our team of dedicated lawyers for help securing compensation to ease the burden.
Compensation for Losses Due to Addiction
Opioid addiction can be destructive and disruptive to individuals and families, causing far-reaching consequences such as a job loss, home loss, extended hospitalization, or loss of child custody. If you’ve experienced a significant loss due to an opioid addiction, you may be eligible for compensation. Contact our lawyers today so we can help to ease your burden.
Assistance for a Child Born With Drug-Related Complications
NAS, or neonatal abstinence syndrome, is a group of conditions that affect babies in the womb when they are exposed to opioid drugs before birth, which can include issues such as poor growth, premature birth, seizures, and birth defects as well as opioid withdrawal symptoms. Opioid-related effects on babies and young children can include learning disabilities, spina bifida, heart and congenital defects, and other developmental disabilities. If you or a child in your care have been affected by complications due to opioid use, our knowledgeable lawyers can help you with the next step toward compensation.
Get Help From Experienced Purdue Pharma Bankruptcy Lawyers Today;
Call Parker Waichman Right Now
Under the agreement tied to the company’s bankruptcy, Purdue Pharma settlement claims can only be filed within a specific window of time. That’s why if you have been affected by one of Purdue Pharma’s drugs, you should contact a lawyer at Parker Waichman as soon as possible. All cases must be signed up by June 1, 2020, so you must act now.
Contact us today by filling out our contact form or calling 212-267-6700 or 800-Just-Call (800-587-8225). We’re here to help.
Purdue Pharma News & LawsuitsPurdue Pharma Faces 1,000 New Individual Law Suits Purdue Pharma Lawsuits In New York. Purdue Pharma, the manufacturer of OxyContin, faces 1,000 separate lawsuits from people who claim they became addicted to the drug. Although OxyContin was approved in 1995 to teat patients with terminal cancer or chronic pain, it has now become a “street drug” that is widely abused for the purpose… [Read more...] Antitrust Probe Against OxyContin Maker Probe Against OxyContin Maker. Connecticut Attorney General Richard Blumenthal is calling on other states to join an investigation into Purdue Pharma, the Stamford, Conn.-based maker of the controversial painkiller OxyContin, the Associated Press reported Jan. 8. Blumenthal said his antitrust probe would determine whether Purdue Pharma prevented the development of less-costly generic alternatives. "We will… [Read more...] Connecticut AG Vows Oxycontin Investigation Painkiller Oxycontin Investigation. Richard Blumenthal, Connecticut's attorney general, said Tuesday he will ask other states to join in investigating whether the maker of the powerful painkiller OxyContin blocked the development of cheaper generic alternatives. The planned antitrust probe came a day after a federal judge found that Stamford-based Purdue Pharma's patents protecting its painkiller were… [Read more...] Purdue Pharma, maker of painkiller OxyContin, starts ad campaign Purdue Pharma Maker Of OxyContin Ad Campaign. The maker of the painkiller OxyContin is starting an advertising campaign in U.S. newspapers to highlight its efforts to combat abuse of the powerful prescription drug. Purdue Pharma's six-month campaign was to begin Thursday, with ads in papers from Maine to Florida. Company officials declined to say how… [Read more...]
A National Law Firm With Offices In:
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation
Get Help From Purdue Pharma Lawyers TodayClick To Get A Free Case Review